@JanSlapeta@Sydney_Uni The majority of the time when you turn up to class the teachers don’t actually teach they just put you into groups and give you group activities to do which is just really disappointing. There is a lot less teaching involved these days it feels like a waste of time turning up.
$VRI @Veriluma 30 healthcare AI algorithms have been FDA approved in US. Many AI algos now detecting and treating health conditions. New research finds AI technology could be as accurate as medical experts in detecting diseases https://t.co/VtgOOj4yp8 via @SmallCapsASX
Consumption and growing demand for #vitamins and dietary supplements in China: https://t.co/f7RXRaQ5Gf
As disposable income increases and wealth gaps narrow, more and more Chinese consumers are focused on improving their health.
$S66 #health#ASX
$MEI Meteoric Resources boosts technical capacity of Board through director appointment https://t.co/1428YD3Ftq via @proactive_au@ASX_MEI#MEI#brighterir
Ardiden shareholder briefing in Perth today at 4.30pm at The George: https://t.co/A1SSsW8iqR
Shareholders are invited to meet CEO Rob Longley, appointed in May and hear an overview of $ADV's Pickle Lake #Gold Project and an update on its Seymour Lake #Lithium Project. #ASX
$5GN @_5GNetworks Chart looks great for reversal of recent downtrend. Perhaps selling of position complete and stock looking excellent value. Growth Strategy is proven.
CEO Brad Marwood is presenting at the @VEvents_RIU Brisbane Resources Round-up 2019 Mining Resources Convention held at the Hilton, Brisbane today at 12.25pm: https://t.co/A9qa4vXg9a
View the latest $CZL presentation here: https://t.co/nOg6lPQyZi
Appointment of new China distributor: https://t.co/vcBzSGQgWa
✅Appointed Guangzhou Yunxing as Optiscan's exclusive pre-clinical distributor for Southern and Western China.
✅Guangzhou Yunxing is a distributor of leading European and other Western pre-clinical equipment. #ASX
$SP3 @Spectur3 Specialty surveillance and property monitoring business, reports a healthy Qtrly Rpt today.
Cash receipts up 84% yoy, Q1F20 rev $1.26m
Expecting near term +ve operating cashflow
Market Cap only $6M with annual rev of $5M+
https://t.co/lJRSPMCSxF
Via @FinancialReview – Why #healthcare is a winner in good times and bad: https://t.co/7ltmIEN8g1
The appeal to investors is the sector's defensive qualities plus the bonus of strong underlying growth via global reach and innovation.
$CDX #ASX#hypertension#cardiovascular
Completion of acquisition of controlling interest in Australian Natural Milk Association Pty Ltd: https://t.co/FXVrcXOPbT
The acquisition accelerates JAT’s strategic plan to insource manufacture of its fast-growing product range & decrease reliance on contract manufacturers.
Credit Suisse upgrades #gold producer @PerseusMining to Outperform and raises price target to $0.88.
"Yaouré extends life visibility materially, increases diversity and grows group production to ~ 500koz/yr" $PRU
Blumio update - completion of Deborah Study & progression to data analysis & Phase 3 of Joint Development Agreement completed: https://t.co/9RWtqKC7RI
$CDX #hearthealth#Cardiovascular
And she's off - Juruena continues to deliver Bonanza #gold grades for @ASX_MEI - 14m @ 81.7 g/t including 2.5m @ a whopping 287.4 g/t https://t.co/V2KfMK5OdE